Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia

被引:0
|
作者
Xue Sun
Hong-yan Gou
Fei Li
Guan-yi Lu
Rui Song
Ri-fang Yang
Ning Wu
Rui-bin Su
Bin Cong
Jin Li
机构
[1] State Key Laboratory of Toxicology and Medical Countermeasures,Department of Forensic Medicine
[2] Beijing Key Laboratory of Neuropsychopharmacology,undefined
[3] Beijing Institute of Pharmacology and Toxicology,undefined
[4] Hebei Key Laboratory of Forensic Medicine,undefined
[5] Hebei Medical University,undefined
来源
关键词
schizophrenia; D; receptor antagonist; positive symptoms; cognitive deficits; haloperidol; clozapine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:322 / 333
页数:11
相关论文
共 49 条
  • [1] Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia
    Sun, Xue
    Gou, Hong-yan
    Li, Fei
    Lu, Guan-yi
    Song, Rui
    Yang, Ri-fang
    Wu, Ning
    Su, Rui-bin
    Cong, Bin
    Li, Jin
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (03) : 322 - 333
  • [2] Antischizophrenic effect of dopamine D3 receptor antagonist Y-QA31
    孙雪
    中国药理学与毒理学杂志, 2012, 26 (03) : 453 - 454
  • [3] KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia
    Park, WK
    Jeong, D
    Cho, H
    Lee, SJ
    Cha, MY
    Pae, AN
    Choi, KI
    Koh, HY
    Kong, JY
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 82 (02) : 361 - 372
  • [4] Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties
    Li, Zhongtang
    Fang, Fan
    Li, Yiyan
    Lv, Xuehui
    Zheng, Ruqiu
    Jiao, Peili
    Wang, Yuxi
    Zhu, Guiwang
    Jin, Zefang
    Xu, Xiangqing
    Qiu, Yinli
    Zhang, Guisen
    Li, Zhongjun
    Liu, Zhenming
    Zhang, Liangren
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (11) : 4553 - 4577
  • [5] Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties
    Zhongtang Li
    Fan Fang
    Yiyan Li
    Xuehui Lv
    Ruqiu Zheng
    Peili Jiao
    Yuxi Wang
    Guiwang Zhu
    Zefang Jin
    Xiangqing Xu
    Yinli Qiu
    Guisen Zhang
    Zhongjun Li
    Zhenming Liu
    Liangren Zhang
    Acta Pharmaceutica Sinica B, 2023, (11) : 4553 - 4577
  • [6] The antipsychotic-like effects in rodents of YQA31 involve dopamine D3 and 5-HT1A receptor
    Hong-Yan Gou
    Xue Sun
    Fei Li
    Zhi-Yuan Wang
    Ning Wu
    Rui-Bin Su
    Bin Cong
    Jin Li
    Pharmacological Reports, 2017, 69 : 1125 - 1130
  • [7] The antipsychotic-like effects in rodents of YQA31 involve dopamine D3 and 5-HT1A receptor
    Gou, Hong-Yan
    Sun, Xue
    Li, Fei
    Wang, Zhi-Yuan
    Wu, Ning
    Su, Rui-Bin
    Cong, Bin
    Li, Jin
    PHARMACOLOGICAL REPORTS, 2017, 69 (06) : 1125 - 1130
  • [8] AT ANTIPSYCHOTIC-LIKE EFFECTIVE DOSES, CARIPRAZINE DISPLAYS POTENT DOPAMINE D3 AND D2 RECEPTOR OCCUPANCY IN VIVO AND EFFICACY ACROSS ANIMAL MODELS
    Adham, N.
    Gyertyn, I.
    Laszlovszky, I.
    Kiss, B.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [9] The dopamine D3 receptor and drug addiction: Studies with preclinical animal models
    Gardner, E
    Ashby, CR
    Xi, ZX
    Pak, AC
    Gilbert, J
    Newman, AH
    Heidbreder, CA
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S18 - S18
  • [10] Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907
    Witkin, J
    Gasior, M
    Acri, J
    Beekman, M
    Thurkauf, A
    Yuan, J
    DeBoer, P
    Wikström, H
    Dijkstra, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 347 (2-3) : R1 - R3